| Infertility update: use of assisted reproductive technology. | |
| | |
MedLine Citation:
|
PMID: 9990189 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To describe assisted reproductive technology (ART) and use of medications during these procedures. DATA SOURCES: Recent clinical literature. STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: ARTs are procedures used in treatment of infertility that involve removal of oocytes and their manipulation outside the woman's uterus. The simplest form of ART, in vitro fertilization, involves aspirating eggs from the ovaries, fertilizing them outside the body, and transferring the embryos into the uterus at the four- to eight-cell stage. Experimental regimens for in vitro fertilization include use of various medications (gonadotropin-releasing hormone agonists, human menotropins, follicle-stimulating hormone, growth hormone) at varying points in the menstrual cycle and after introduction of the embryo into the uterus. Human chorionic gonadotropin has been used to increase implantation of embryos during the woman's luteal phase. Gamete intrafallopian transfer (GIFT) involves transfer of oocytes and sperm into the fallopian tubes, where fertilization takes place. This technique has the advantage of causing the zygote to enter the uterus at the time it would during natural conception. Zygote intrafallopian transfer is similar to GIFT, except that fertilization occurs in vitro, with embryos placed in the fallopian tubes at the two-cell stage. Various micromanipulation techniques and innovative sperm aspiration procedures are currently under development. CONCLUSION: Many advancements have been made in ART, and pharmacists who understand these procedures can serve patients by providing medication information in an empathetic and supportive manner. |
| | |
Authors:
|
T M Yoshida |
Related Documents
:
|
16125349 - Tissue microarray technology: principles, pitfalls and perspectives--lessons learned fr... 15967369 - Intellectual property strategy in bioinformatics and biochips. 17058339 - Desperately seeking donors: the 'saviour sibling' decision in quintavalle v human ferti... 11104459 - The use of information technology in improving medical performance. part ii. physician-... 17377279 - Avatars alive! the integration of physiology models and computer generated avatars in a... 15823849 - Womb with a view. 7659209 - Neuropharmacological therapy and motor recovery after stroke. 8018739 - A study of the use of clonidine and naltrexone in the treatment of opioid addiction in ... 9721579 - When patients request the impotence pill. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) Volume: 39 ISSN: 1086-5802 ISO Abbreviation: J Am Pharm Assoc (Wash) Publication Date: 1999 Jan-Feb |
Date Detail:
|
Created Date: 1999-03-24 Completed Date: 1999-03-24 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9601004 Medline TA: J Am Pharm Assoc (Wash) Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 65-72; quiz 103-4 Citation Subset: IM |
Affiliation:
|
TMYoshida@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Fertility Agents / therapeutic use Humans Infertility / therapy* Male Pregnancy Reproductive Techniques* |
| Chemical | |
Reg. No./Substance:
|
0/Fertility Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Billing third party payers for pharmaceutical care services.
Next Document: Analysis of grocery chain pharmacists' work-related behaviors.